Shares of Pfizer (NYSE:PFE) Sees Large Inflow of Net Money Flow

Pfizer (NYSE:PFE) dropped by -1.22 or -0.43 points during the last session to $34.33 per share. One of the highlights of the day was the net money flow figure, which stood at $130.51 million even as the stock accepted $188.06 million in upticks but rejected $57.55 million in downticks. The up/down ratio for the last observation was a 3.27. The 1-week percentage change for the stock price is registered at -2.73%.A block transaction occurred with $133.75 million in upticks and $1.4 million in downticks while the up/down ratio was calculated to be 95.54. The stock witnessed a net inflow of $132.35 million at the end of the block trade.

Pfizer Inc. has dropped 3.03% in the last five trading days, however, the shares have posted positive gains of 3.17% in the last 4 weeks. Pfizer Inc. is up 17.24% in the last 3-month period. Year-to-Date the stock performance stands at 8.03%.

Currently the company Insiders own 0.07% of Pfizer shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -18.54% . Institutional Investors own 75.07% of Pfizer shares. During last six month period, the net percent change held by insiders has seen a change of -18.54%. . On the companys insider trading activities, The officer (Executive Vice President), of Pfizer Inc, Damelio Frank A had unloaded 100,000 shares at $34.49 per share in a transaction on May 26, 2016. The total value of transaction was $3,449,000. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.

Pfizer (NYSE:PFE) witnessed a decline in the market cap on Friday as its shares dropped 1.53% or 0.53 points. After the session commenced at $34.78, the stock reached the higher end at $34.81 while it hit a low of $34.055. With the volume soaring to 33,608,565 shares, the last trade was called at $34.22. The company has a 52-week high of $36.46. The company has a market cap of $207,539 million and there are 6,064,849,400 shares in outstanding. The 52-week low of the share price is $28.25.

Pfizer Inc. is a global biopharmaceutical company. The Company is engaged in discovering, developing and manufacturing of healthcare products. Its products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Sutent, EpiPen, Toviaz, Tygacil, Rapamune, Xalkori, Inlyta, Norvasc, BeneFIX, Genotropin and Enbrel, among others. It operates in three segments: Global Innovative Pharmaceutical segment (GIP), Global Vaccines, Oncology and Consumer Healthcare segment (VOC) and Global Established Pharmaceutical segment (GEP). GIP is focused on developing, registering and commercializing medications in therapeutic areas, such as inflammation, cardiovascular/metabolic, neuroscience and pain, rare diseases and womens/mens health. VOC focuses on the development and commercialization of vaccines and products for oncology and consumer healthcare. GEP includes its sterile injectable products and bio similar development portfolio. Its subsidiary is Hospira, Inc.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.